Body function outcome | Primary only | 19 % (16/84) |
Secondary only | 6 % (5/84) | |
Primary and secondary | 56 % (47/84) | |
Unclear | 13 % (11/84) | |
Multiple primary outcomes | 29 % (24/84) | |
Number of arms | 2 | 81 % (68/84) |
Number of patients per arm | Median (range) | 18.8 (6–182) |
Type of study | Comparison of treatment | 35 % (29/84) |
Comparison with placebo/usual care | 80 % (67/84) | |
Cross-over design | 5 % (4/84) | |
Duration of follow-up | median (range) of duration | 3 (0.3–60) months |
Number of follow-up measures | 2 | 55 % (46/84) |
4 | 35 % (29/84) | |
Other (3,5, unclear) | 11 % (9/84) |